Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Donate to our blog

Your support will help Science & Enterprise continue to provide science news for business people and business news for scientists.

Antibody Shows Promise Against Marburg Virus Infections

Tests with lab animals show an experimental synthetic antibody protects against deadly Marburg and Ravn viruses as long as 5 days following infections. . . . → Read More: Antibody Shows Promise Against Marburg Virus Infections

Umbilical Cord Blood Evaluated for Autism Treatment

Results from a clinical trial show infusions of a child’s own umbilical cord blood are safe for treating autism spectrum disorder, and provide initial signs of effectiveness. . . . → Read More: Umbilical Cord Blood Evaluated for Autism Treatment

Prodrugs Designed to Better Target Cancer Therapies

A delivery mechanism is being developed to package cancer drugs in a nanoscale precursor state that reacts only in tumor regions, to protect against adverse effects. . . . → Read More: Prodrugs Designed to Better Target Cancer Therapies

Artificial Pancreas Shown Feasible for Young Children

An integrated system combining a glucose monitor and insulin pump to simulate the human pancreas is shown to be feasible for young children with type 1 diabetes. . . . → Read More: Artificial Pancreas Shown Feasible for Young Children

Triple-Drug Inhaler Shown to Cut COPD Attacks

Results from a year-long clinical trial show that an inhaler with three types of drugs reduces the number of COPD attacks compared to a common single-drug inhaler. . . . → Read More: Triple-Drug Inhaler Shown to Cut COPD Attacks

Enhanced Gene Therapy Boosts Anti-Tumor Response

Gene therapies delivered with electronic pulses were shown in lab mice to increase production of natural immune-system proteins and reduce melanoma, or advanced skin cancer, tumors. . . . → Read More: Enhanced Gene Therapy Boosts Anti-Tumor Response

Zika DNA Vaccine Begins Clinical Trial

A new clinical trial is underway testing a Zika vaccine that uses genetically-engineered DNA to generate an immune response against the disease. . . . → Read More: Zika DNA Vaccine Begins Clinical Trial

Univ. Spin-Off Designing Heart Disease Screening App

A spin-off enterprise from Massachusetts Institute of Technology is creating a system using a smartphone camera to detect heart rhythm problems that lead to a stroke. . . . → Read More: Univ. Spin-Off Designing Heart Disease Screening App

Climate-Resistant Oilseed Crop Plant Developed

An academic-industry team developed a new crop plant variety that produces cooking oil like rapeseed or canola, but in a warmer and dryer climate. . . . → Read More: Climate-Resistant Oilseed Crop Plant Developed

Diet Enhancing Gut Microbes Shown to Slow Type 1 Diabetes

A diet that produces certain short-chain fatty acids in the gut is shown in lab mice to support the immune system and slow the onset of type 1 diabetes. . . . → Read More: Diet Enhancing Gut Microbes Shown to Slow Type 1 Diabetes